Schedule of Additional Information Regarding Profit or Loss Items |
| |
For the year ended December 31, | |
| |
2024 | | |
2023 | | |
2022 | |
A. Revenue | |
| | |
| | |
| |
Breakdown of revenue by geography | |
| | |
| | |
| |
Israel | |
| 6,814 | | |
| 4,947 | | |
| 5,423 | |
Europe | |
| 240 | | |
| 423 | | |
| 146 | |
Asia | |
| 1,198 | | |
| 1,072 | | |
| 127 | |
USA | |
| 841 | | |
| 1,070 | | |
| 1,477 | |
Other | |
| 1 | | |
| 121 | | |
| 91 | |
| |
| 9,094 | | |
| 7,633 | | |
| 7,264 | |
| |
For the year ended
December 31, | |
| |
2024 | | |
2023 | | |
2022 | |
Revenues from key customers, each of which is responsible for 10% or more of the total revenues reported
in the Consolidated Financial Statements: | |
| | |
| | |
| |
Customer 1 | |
| 4,097 | | |
| 2,559 | | |
| 516 | |
Customer 2 | |
| 1,332 | | |
| 908 | | |
| 4,016 | |
| |
| 5,429 | | |
| 3,467 | | |
| 4,532 | |
| |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
Trade receivables balance from key customers: | |
| | | |
| | | |
| | |
Customer 1 | |
| 648 | | |
| 1,592 | | |
| 39 | |
Customer 2 | |
| 365 | | |
| 469 | | |
| 2,098 | |
| |
| 1,013 | | |
| 2,061 | | |
| 2,137 | |
Revenue by product group: | |
| | | |
| | | |
| | |
In-Ear Headset systems | |
| 4,945 | | |
| 4,532 | | |
| 6,038 | |
SST Headset systems | |
| 3,818 | | |
| 2,713 | | |
| 749 | |
Other | |
| 331 | | |
| 388 | | |
| 477 | |
| |
| 9,094 | | |
| 7,633 | | |
| 7,264 | |
| |
| | | |
| | | |
| | |
| |
For the year ended December 31, | |
| |
2024 | | |
2023 | | |
2022 | |
B. Cost of revenue | |
| | |
| | |
| |
Salaries and related expenses* | |
| 1,190 | | |
| 1,139 | | |
| 648 | |
Purchases | |
| 4,452 | | |
| 3,164 | | |
| 4,667 | |
Depreciation and amortization | |
| 64 | | |
| 61 | | |
| 55 | |
Decrease (increase) in inventory | |
| (633 | ) | |
| (49 | ) | |
| (686 | ) |
Other | |
| 217 | | |
| 149 | | |
| 152 | |
| |
| 5,290 | | |
| 4,464 | | |
| 4,836 | |
* Includes share-based compensation of $137 in 2024 and $421 in 2023. | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
C. Research and development expenses* | |
| | | |
| | | |
| | |
Salaries and related expenses | |
| 518 | | |
| 980 | | |
| 311 | |
Purchases | |
| 8 | | |
| 3 | | |
| 6 | |
Professional consulting | |
| 6 | | |
| 15 | | |
| 91 | |
Depreciation and amortization | |
| 14 | | |
| 19 | | |
| 9 | |
Other | |
| 31 | | |
| 31 | | |
| 22 | |
| |
| 577 | | |
| 1,048 | | |
| 439 | |
| |
| | | |
| | | |
| | |
* Includes share-based compensation of $160 in 2024 and $541 in 2023. | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
D. Selling and marketing expenses* | |
| | | |
| | | |
| | |
Salaries and related expenses | |
| 1,116 | | |
| 2,969 | | |
| 537 | |
Exhibitions and advertising | |
| 119 | | |
| 46 | | |
| 38 | |
Depreciation and amortization | |
| 11 | | |
| 25 | | |
| 23 | |
Other | |
| 121 | | |
| 130 | | |
| 74 | |
| |
| 1,367 | | |
| 3,170 | | |
| 672 | |
* Includes share-based compensation of $284 in 2024 and $2,467 in 2023. | |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
E. General and administrative expenses* | |
| | | |
| | | |
| | |
Salaries and related expenses | |
| 1,121 | | |
| 1,400 | | |
| 529 | |
Professional services | |
| 1,799 | | |
| 131 | | |
| 102 | |
Rent and maintenance | |
| 105 | | |
| 57 | | |
| 60 | |
Depreciation and amortization | |
| 52 | | |
| 26 | | |
| 10 | |
Other | |
| 248 | | |
| 118 | | |
| 136 | |
| |
| 3,325 | | |
| 1,732 | | |
| 837 | |
* Includes share-based compensation of $279 in 2024 and $807 in 2023. | |
| | | |
| | | |
| | |
| |
For the year ended December 31, | |
| |
2024 | | |
2023 | | |
2022 | |
F. Other expenses | |
| | |
| | |
| |
Capital loss | |
| 5 | | |
| - | | |
| - | |
| |
| 5 | | |
| - | | |
| - | |
| |
| | | |
| | | |
| | |
| |
| | | |
| | | |
| | |
G. Finance expenses | |
| | | |
| | | |
| | |
In respect of lease liabilities | |
| 34 | | |
| 12 | | |
| 10 | |
In respect of credit from related parties | |
| - | | |
| - | | |
| - | |
In respect of credit from banking corporations | |
| 14 | | |
| 9 | | |
| 34 | |
In respect of credit from others | |
| - | | |
| - | | |
| - | |
Revaluation of a SAFE | |
| 47 | | |
| 53 | | |
| 22 | |
Revaluation of a liability in respect of a warrants | |
| - | | |
| 12 | | |
| - | |
Other | |
| 29 | | |
| 18 | | |
| 57 | |
| |
| 124 | | |
| 104 | | |
| 123 | |
| |
| | | |
| | | |
| | |
H. Finance income | |
| | | |
| | | |
| | |
Securities income | |
| 81 | | |
| - | | |
| - | |
Revaluation of a liability in respect of warrants | |
| - | | |
| - | | |
| 1,237 | |
Exchange rate differentials | |
| 31 | | |
| 67 | | |
| 206 | |
Other | |
| 15 | | |
| - | | |
| - | |
| |
| 127 | | |
| 67 | | |
| 1,443 | |
|